Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases
Immunotherapy using dendritic cell-based vaccination is a natural approach using the capabilities and functions inherent in the patient’s immune system to eliminate tumor cells. The development of dendritic cell-based cell technologies evolved as the disorders of dendritic cell differentiation and f...
Main Authors: | Vasily Kurilin, Alina Alshevskaya, Sergey Sennikov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/3/699 |
Similar Items
-
EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
by: V. V. Kurilin, et al.
Published: (2021-10-01) -
Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
by: Byeong Hoon Kang, et al.
Published: (2022-06-01) -
The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment
by: Anna Valerevna Gorodilova, et al.
Published: (2023-10-01) -
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
by: Jianmei W. Leavenworth, et al.
Published: (2022-09-01) -
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
by: Elena V. Abakushina, et al.
Published: (2021-11-01)